Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study

Limited data are available about the cardiovascular (CV) safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in ischemic stroke patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). Ischemic stroke patients with T2DM and CKD were selected from the Taiwan National Health Insurance Research Database (NHIRD) from March 1, 2009 to December 31, 2011. A total of 1375 patients were divided into 2 age- and gender-matched groups: patients who received sitagliptin (n = 275; 20%) and those who did not (n = 1,100). Primary major adverse cardiac and cerebrovascular events (MACCE), including ischemic stroke, hemorrhagic stroke, myocardial infarction (MI), or CV death, were evaluated. During a mean 1.07-year follow-up period, 45 patients (16.4%) in the sitagliptin group and 165 patients (15.0%) in the comparison group developed MACCEs (Hazard ratio [HR] 1.05; 95% confidence interval [CI], 0.75–1.45). Compared to the non-sitagliptin group, the sitagliptin group had a similar risk of ischemic stroke (HR 0.82; 95% CI, 0.51–1.32.), hemorrhagic stroke (HR 1.50; 95% CI, 0.58–3.82), MI (HR 1.14; 95% CI, 0.49–2.65), and CV mortality (HR 1.06; 95% CI, 0.61–1.85). The use of sitagliptin in recent ischemic stroke patients with T2DM and CKD was not associated with increased or decreased risk of adverse CV events.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

Related Links:

A new study examines the question of whether thromboprophylaxis is needed to prevent VTE complications after adrenalectomy.Journal of the Endocrine Society
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Diabetes & Endocrinology Journal Article Source Type: news
(Society of Interventional Radiology) Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients experiencing stroke, according to a study presented today at the Society of Interventional Radiology Annual Scientific Meeting. Expanding access to this treatment provides patients timely access to this gold-standard treatment.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Our weekly DiabetesMine series of cartoons and memes for the diabetes community features a cartoon by Jon Carter.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
This study assed the effect of saffron as a neuroprotective natural product in cerebral ischemia in human.Study designPatients with acute ischemic stroke were randomly allocated to receive either routine stroke care (control group, n = 20) or routine care plus aqueous extract of saffron capsule (200 mg/day) (saffron-treated group, n = 19). Both groups were monitored during their four-day hospital stay and the three-month follow-up period. The groups were compared in terms of short- and long-term effects of saffron capsules using the National Institute of Health Stoke Scale (NIHSS), Barthel Scale, and serum neuron...
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
This study was aimed at assessing the vasoconstrictor component of atherothrombotic culprit lesions in patients with STEMI receiving primary percutaneous coronary intervention (PCI).Methods100 patients with STEMI were enrolled prospectively. Baseline coronary angiography achieving normal antegrade flow was followed by 200μg of intracoronary nitroglycerin (NTG) injection and repeat coronary angiography at the same projection view for culprit lesions was performed. End points were the changes in lesion length, reference vessel diameter, minimal lumen diameter and diameter stenosis by quantitative coronary analysis before ...
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research
This study adopted hydrophilic and positively charged α-poly-l-lysine (αPLL) as the entrapment matrix for the immobilization of negatively charged glucose oxidase (GOx) and ferricyanide (FIC) on SPCEs to construct a disposable second-generation glucose biosensor. The αPLL modification is shown to facilitate the redox kinetics of FIC and ferrocyanide on the SPCEs. The SPCEs coated with 0.5 mM GOx, 99.5 mM FIC, and 5 mM αPLL had better sensitivity for glucose detection due to the appreciable effect of protonated αPLL on the promotion of electron transfer between GOx and FIC. ...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
' A reasonable HbA1c goal for many nonpregnant adults with diabetes is
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
(MedPage Today) -- Positive results from PIONEER 3 trial in diabetic patients who aren't responding to metformin with or without sulfonylurea
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
Publication date: Available online 23 March 2019Source: NeuroImageAuthor(s): Sharmili Edwin Thanarajah, Sandra Iglesias, Bojana Kuzmanovic, Lionel Rigoux, Klaas E. Stephan, Jens C. Brüning, Marc TittgemeyerAbstractInsulin modulates dopamine neuron activity in midbrain and affects processes underlying food intake behaviour, including impulsivity and reward processing. Here, we used intranasal administration and task-free functional MRI in humans to assess time- and dose-dependent effects of insulin on functional connectivity of the dopaminergic midbrain – and how these effects varied depending on systemic insulin...
Source: NeuroImage - Category: Neuroscience Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Health Insurance | Heart | Heart Attack | Hemorrhagic Stroke | Insurance | Internal Medicine | Ischemic Stroke | Januvia | Stroke | Study | Taiwan Health | Urology & Nephrology